Pasithea Therapeutics Corp. and Evotec SE Enter into Drug Development Agreement
11 oct. 2021 06h50 HE
|
Pasithea
MIAMI BEACH, Fla., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new...
Pasithea Therapeutics Corp. to Present at the Benzinga Healthcare Small Cap Conference
29 sept. 2021 16h30 HE
|
Pasithea
MIAMI BEACH, Fla., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new...
Pasithea Therapeutics Corp. Announces Closing of $24.0 Million Initial Public Offering
17 sept. 2021 16h05 HE
|
Pasithea
MIAMI BEACH, Fla., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new...
Pasithea Therapeutics Corp. Announces Pricing of Upsized $24.0 Million Initial Public Offering
14 sept. 2021 21h04 HE
|
Pasithea
MIAMI BEACH, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. ("Pasithea" or the "Company"), a biotechnology company focused on the research and discovery of new and effective...